Transpaco Limited (JSE:TPC)

CTI BioPharma Balance Sheet

Financials in millions ZAR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	70.36	160.57	166.68	72.25	76.25	60.82
Short-Term Investments	-	2.35	1.36	1.33	1.39	1.13
Cash & Short-Term Investments	70.36	162.92	168.04	73.58	77.64	61.95
Cash Growth	-3.71%	-3.05%	128.39%	-5.23%	25.33%	26.05%
Accounts Receivable	505.4	359.98	322.26	382.06	302.03	255.41
Other Receivables	2.16	12.11	11.53	15.04	13.22	16.23
Receivables	507.56	372.09	333.79	397.1	315.24	271.64
Inventory	273.36	279.49	308.17	329.72	245.22	210.49
Prepaid Expenses	-	49.88	32.23	17.39	26.18	17.41
Other Current Assets	-	-	-	0.18	20.15	10.06
Total Current Assets	851.29	864.38	842.23	817.96	684.43	571.55
Property, Plant & Equipment	530.23	503.4	526.33	534	535.48	462.75
Goodwill	64.18	64.18	64.18	64.18	64.18	64.18
Other Intangible Assets	17.86	17.86	17.86	17.86	17.86	17.86
Long-Term Deferred Tax Assets	7.75	8.3	7.61	5.78	6.55	4.53
Total Assets	1,476	1,463	1,463	1,443	1,311	1,121
Accounts Payable	317.36	201.7	206.7	252.55	166.5	156.17
Accrued Expenses	-	158.28	139.14	118.19	113.43	90.17
Current Portion of Long-Term Debt	25.35	6.11	4.69	4.91	6.24	1.4
Current Portion of Leases	12.13	35.88	47.64	43.12	49.92	43.84
Current Income Taxes Payable	6	0.16	1.65	1.82	3.51	4.65
Current Unearned Revenue	0.09	0.13	0.24	0.86	5.11	1.13
Other Current Liabilities	-	1.69	1.59	-	4.72	0.29
Total Current Liabilities	360.94	403.95	401.66	421.44	349.42	297.65
Long-Term Debt	91.72	43	48.24	52.59	62.68	6.65
Long-Term Leases	10.69	34.04	83.42	102.1	124.59	98.44
Long-Term Unearned Revenue	0.43	0.46	0.59	0.88	1.66	2.61
Long-Term Deferred Tax Liabilities	48.45	49.14	43.2	38.23	38.84	35.98
Total Liabilities	512.22	530.59	577.11	615.23	577.19	441.34
Common Stock	0.29	0.29	0.3	0.31	0.32	0.33
Additional Paid-In Capital	9.66	9.66	10.03	10.55	10.67	11.02
Retained Earnings	953.64	922.09	875.27	816.68	723.31	668.17
Shareholders' Equity	963.59	932.04	885.6	827.54	734.3	679.52
Total Liabilities & Equity	1,476	1,463	1,463	1,443	1,311	1,121
Total Debt	139.89	119.03	183.99	202.71	243.43	150.33
Net Cash (Debt)	-69.52	43.88	-15.95	-129.13	-165.79	-88.38
Net Cash Per Share	-2.41	1.50	-0.51	-4.08	-5.07	-2.69
Filing Date Shares Outstanding	28.84	28.84	29.94	31.5	31.84	32.89
Total Common Shares Outstanding	28.84	28.84	29.94	31.5	31.84	32.89
Working Capital	490.35	460.43	440.57	396.52	335	273.9
Book Value Per Share	33.41	32.32	29.58	26.27	23.06	20.66
Tangible Book Value	881.55	850	803.56	745.51	652.26	597.48
Tangible Book Value Per Share	30.57	29.47	26.84	23.67	20.49	18.17
Land	-	209.7	209.08	206.43	196.29	129.21
Machinery	-	779.66	753.8	700.29	668.43	596.22
Construction In Progress	-	9.7	0.09	5.71	8.31	38.96

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.